The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock
Yıl: 2021 Cilt: 5 Sayı: 1 Sayfa Aralığı: 153 - 158 Metin Dili: İngilizce DOI: 10.14744/ejmi.2021.43319 İndeks Tarihi: 18-06-2021
The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock
Öz: Objectives: Severe sepsis and septic shock are among the most important causes of death in the intensive care units.Sepsis is a severe stress condition. Hypothalamic-pituitary-adrenal axis plays an important role in response to stress.The increase in cortisol level is important in maintaining vascular reactivity, regulating the immune response, and ensuring the balance of the body during acute disease. Adiponectin is an adipocytokine released from adipose tissue,which is now thought to play a role in the pathogenesis of diseases such as diabetes mellitus, atherosclerosis, malignancy, and sepsis, with its anti-inflammatory, insulin-sensitizing, and anti-atherosclerotic effects. The aim of this study isto investigate the relationship of cortisol and anti-inflammatory adiponectin, which are effective in the stress responseof the body, with metabolic parameters, inflammation, and prognosis in the patients diagnosed with sepsis.Methods: Twenty-nine patients who were admitted to Gazi University, Faculty of Medicine Internal Diseases IntensiveCare Unit with the diagnoses of severe sepsis and septic shock, 23 patients who were admitted to the unit for a reasonother than sepsis, and 22 healthy outpatients of similar age were included in the study. Blood samples of the patientswere collected, and their demographic data were recorded during their admission to the intensive care unit.Results: Although not statistically significant, serum adiponectin level was higher in the septic shock group comparedto the other two groups (p=0.217). Serum adiponectin levels observed after recovering from sepsis were found tobe significantly increased compared to the levels at the time of diagnosis (p<0.001). Serum adiponectin levels werefound to have no significant effect on mortality (p=0.423). Serum cortisol levels were statistically significantly higherin the patients with sepsis compared to those without sepsis (p=0.0001). In addition, a positive correlation was foundbetween serum adiponectin level and cortisol (r=0.49, p=0.013). There was also a negative correlation between serumadiponectin level and C-reactive protein level (r=-0.331, p=0.019).Conclusion: Our findings suggest that adiponectin plays a role in sepsis as a part of the inflammatory and metabolicresponse. Prospective studies examining more cases are needed to use adiponectin as a prognostic marker in the patients with sepsis.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
- 1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992;101:1644–55.
- 2. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63–78.
- 3. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296–327.
- 4. Trayhurn P, Beattie JH. Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329–39.
- 5. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006;8:264–80.
- 6. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746–9.
- 7. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697–703.
- 8. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286–9.
- 9. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473–6.
- 10. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296–301.
- 11. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723–32.
- 12. Peake PW, Shen Y, Campbell LV, Charlesworth JA. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun 2006;341:108–15.
- 13. Tsuchihashi H, Yamamoto H, Maeda K, Ugi S, Mori T, Shimizu T, et al. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res 2006;134:348–53.
- 14. Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 2007;75:235–40.
- 15. Koch A, Sanson E, Voigt S, Helm A, Trautwein C, Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011;26:166–74.
- 16. Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den Berghe G. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care 2009;13:R112.
- 17. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003;52:942–7.
- 18. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and Type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930–5.
- 19. Koshimura J, Fujita H, Narita T, Shimotomai T, Hosoba M, Yoshioka N, et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004;316:165–9.
- 20. Chudek J, Adamczak M, Karkoszka H, Budziński G, Ignacy W, Funahashi T, et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003;35:2186–9.
- 21. Keller P, Møller K, Krabbe KS, Pedersen BK. Circulating adiponectin levels during human endotoxaemia. Clin Exp Immunol 2003;134:107–10.
| APA | demir h, Törüner F, Bukan N (2021). The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. , 153 - 158. 10.14744/ejmi.2021.43319 |
| Chicago | demir hacer,Törüner Füsun,Bukan Neslihan The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. (2021): 153 - 158. 10.14744/ejmi.2021.43319 |
| MLA | demir hacer,Törüner Füsun,Bukan Neslihan The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. , 2021, ss.153 - 158. 10.14744/ejmi.2021.43319 |
| AMA | demir h,Törüner F,Bukan N The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. . 2021; 153 - 158. 10.14744/ejmi.2021.43319 |
| Vancouver | demir h,Törüner F,Bukan N The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. . 2021; 153 - 158. 10.14744/ejmi.2021.43319 |
| IEEE | demir h,Törüner F,Bukan N "The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock." , ss.153 - 158, 2021. 10.14744/ejmi.2021.43319 |
| ISNAD | demir, hacer vd. "The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock". (2021), 153-158. https://doi.org/10.14744/ejmi.2021.43319 |
| APA | demir h, Törüner F, Bukan N (2021). The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. Eurasian Journal of Medical Investigation, 5(1), 153 - 158. 10.14744/ejmi.2021.43319 |
| Chicago | demir hacer,Törüner Füsun,Bukan Neslihan The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. Eurasian Journal of Medical Investigation 5, no.1 (2021): 153 - 158. 10.14744/ejmi.2021.43319 |
| MLA | demir hacer,Törüner Füsun,Bukan Neslihan The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. Eurasian Journal of Medical Investigation, vol.5, no.1, 2021, ss.153 - 158. 10.14744/ejmi.2021.43319 |
| AMA | demir h,Törüner F,Bukan N The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. Eurasian Journal of Medical Investigation. 2021; 5(1): 153 - 158. 10.14744/ejmi.2021.43319 |
| Vancouver | demir h,Törüner F,Bukan N The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock. Eurasian Journal of Medical Investigation. 2021; 5(1): 153 - 158. 10.14744/ejmi.2021.43319 |
| IEEE | demir h,Törüner F,Bukan N "The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock." Eurasian Journal of Medical Investigation, 5, ss.153 - 158, 2021. 10.14744/ejmi.2021.43319 |
| ISNAD | demir, hacer vd. "The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock". Eurasian Journal of Medical Investigation 5/1 (2021), 153-158. https://doi.org/10.14744/ejmi.2021.43319 |
